3D Signatures Competitors

Akumin (TSE:AKU) and 3D Signatures (CVE:DXD) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitability and earnings.

Profitability

This table compares Akumin and 3D Signatures' net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Akumin and 3D Signatures' revenue, earnings per share and valuation.

3D Signatures has lower revenue, but higher earnings than Akumin. Akumin is trading at a lower price-to-earnings ratio than 3D Signatures, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current recommendations for Akumin and 3D Signatures, as reported by MarketBeat.com.

Akumin presently has a consensus target price of C$4.25, suggesting a potential upside of 10.39%. Given Akumin's higher possible upside, analysts clearly believe Akumin is more favorable than 3D Signatures.

Summary

Akumin beats 3D Signatures on 3 of the 5 factors compared between the two stocks.

LexaGene (CVE:LXG) and 3D Signatures (CVE:DXD) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, earnings, profitability, analyst recommendations, institutional ownership and valuation.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for LexaGene and 3D Signatures, as provided by MarketBeat.com.

Earnings and Valuation

This table compares LexaGene and 3D Signatures' revenue, earnings per share and valuation.

LexaGene is trading at a lower price-to-earnings ratio than 3D Signatures, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares LexaGene and 3D Signatures' net margins, return on equity and return on assets.

Summary

3D Signatures beats LexaGene on 2 of the 2 factors compared between the two stocks.

SQI Diagnostics (CVE:SQD) and 3D Signatures (CVE:DXD) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.

Earnings and Valuation

This table compares SQI Diagnostics and 3D Signatures' gross revenue, earnings per share and valuation.

3D Signatures has lower revenue, but higher earnings than SQI Diagnostics. SQI Diagnostics is trading at a lower price-to-earnings ratio than 3D Signatures, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares SQI Diagnostics and 3D Signatures' net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for SQI Diagnostics and 3D Signatures, as reported by MarketBeat.

Summary

SQI Diagnostics beats 3D Signatures on 2 of the 3 factors compared between the two stocks.

3D Signatures (CVE:DXD) and Sernova (CVE:SVA) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, valuation and risk.

Earnings & Valuation

This table compares 3D Signatures and Sernova's gross revenue, earnings per share and valuation.

Sernova is trading at a lower price-to-earnings ratio than 3D Signatures, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares 3D Signatures and Sernova's net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of current ratings and price targets for 3D Signatures and Sernova, as reported by MarketBeat.

3D Signatures (CVE:DXD) and GeneNews (TSE:GEN) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, institutional ownership, valuation and profitability.

Valuation and Earnings

This table compares 3D Signatures and GeneNews' gross revenue, earnings per share and valuation.

3D Signatures has higher earnings, but lower revenue than GeneNews. 3D Signatures is trading at a lower price-to-earnings ratio than GeneNews, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current recommendations for 3D Signatures and GeneNews, as provided by MarketBeat.

Profitability

This table compares 3D Signatures and GeneNews' net margins, return on equity and return on assets.

Summary

3D Signatures beats GeneNews on 2 of the 3 factors compared between the two stocks.

LED Medical Diagnostics (CVE:LMD) and 3D Signatures (CVE:DXD) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, risk, analyst recommendations and institutional ownership.

Valuation and Earnings

This table compares LED Medical Diagnostics and 3D Signatures' revenue, earnings per share and valuation.

3D Signatures has lower revenue, but higher earnings than LED Medical Diagnostics. LED Medical Diagnostics is trading at a lower price-to-earnings ratio than 3D Signatures, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings and target prices for LED Medical Diagnostics and 3D Signatures, as reported by MarketBeat.

Profitability

This table compares LED Medical Diagnostics and 3D Signatures' net margins, return on equity and return on assets.

Summary

LED Medical Diagnostics beats 3D Signatures on 2 of the 3 factors compared between the two stocks.